More stories
Workers' Comp
Podcast
Chronicling the World of Workers’ Comp with Roberto Ceniceros
Last month, workers’ compensation lost one of its most talented reporters and influencers as Roberto Ceniceros announced his retirement.
Workers' Comp
Article
Gabapentinoids in Workers’ Compensation
Nearly 20 percent of U.S. adults suffer from chronic pain. This is especially vital in the workers’ compensation world that is now asking, ‘are gabapentinoids the answer to that pain?’ Current increases in prescribing of gabapentinoids and the drugs’ less addictive qualities as compared to opioids may initially suggest so.
Workers' Comp
Blog
Destination Care
Destination care, centers of excellence, medical tourism, benefit driven travel and geographically recognized care centers – mean what exactly? And if the concept is quickly growing in popularity for group health patients, can it be applied for workers’ compensation claimants too?
Auto Casualty
Article
The Power of Technology Enabled Services: Balancing Technology with the Human Touch
While technology and automation have dominated the conversation in the insurance industry for the past few years, it is important that the property and casualty industry understands the importance of digitizing while maintaining the element of human touch in claims processing.
Mitchell
News Release
Puerto Rico Governor Declares State of Emergency
Updates to how injured workers can access care in the wake of a 6.4 magnitude earthquake in Puerto Rico.
Workers' Comp
Blog
WHY USE ANTICONVULSANTS TO TREAT PAIN?
A fuller awareness of the risks, costs, and consequences of opioid medication use in clinical pain management is growing, and the search for safe, effective, and affordable alternatives to them has taken on new urgency. The quest for opioid alternatives that offer a measure of effective analgesia (without craving, tolerance, and addiction) is taking on an increased priority in discovery laboratories and across the ranks of practicing clinicians and other health care professionals. Beyond new discovery, another potential source of such alternatives is in reevaluating existing medications approved for pain as well as those approved for other uses that may also hold promise for use as analgesics.